Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,880 | 107,511 | 73,487 | 124,010 | 76,677 |
| Marketable Securities | 63,633 | 196,421 | 108,943 | 124,921 | 115,158 |
| TOTAL | $149,077 | $312,619 | $189,111 | $251,680 | $197,457 |
| Non-Current Assets | |||||
| PPE Net | 28,604 | 26,328 | 17,205 | 10,391 | 2,702 |
| Investments And Advances | 14,661 | 0 | 0 | 33,602 | 7,992 |
| Other Non-Current Assets | 12,027 | 608 | 618 | 3,116 | 4,210 |
| TOTAL | $55,292 | $26,936 | $17,823 | $47,109 | $14,904 |
| Total Assets | $204,369 | $339,555 | $206,934 | $298,789 | $212,361 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,882 | 8,833 | 5,095 | 1,427 | 1,863 |
| Accrued Expenses | 31,286 | 29,144 | 21,478 | 9,921 | 3,118 |
| Other current liabilities | 23 | 35 | 26 | 102 | 117 |
| TOTAL | $47,448 | $38,012 | $26,599 | $11,450 | $5,098 |
| Non-Current Liabilities | |||||
| Long Term Debt | 41,028 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 11,869 | 2,596 | 2,530 | 1,367 | 1,012 |
| TOTAL | $52,897 | $2,596 | $2,530 | $1,367 | $1,012 |
| Total Liabilities | $100,345 | $40,608 | $29,129 | $12,817 | $6,110 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,042 | 62,186 | 51,526 | 50,249 | 42,239 |
| Common Shares | 6 | 6 | 5 | 5 | 4 |
| Retained earnings | -724,680 | -476,234 | -265,482 | -134,157 | -53,333 |
| Other shareholders' equity | 80 | -108 | -108 | -27 | -88 |
| TOTAL | $104,024 | $298,947 | $177,805 | $285,972 | $206,251 |
| Total Liabilities And Equity | $204,369 | $339,555 | $206,934 | $298,789 | $212,361 |